New Season of “I am BIO” Podcast Explores Patient Stories, Weight Loss Drugs, Food Security, and More
Series delves into biotech breakthroughs, the people they help, and the global problems they solve
WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of biotechnology, life sciences, environment, and agriculture. “I am BIO” highlights stories of resilience, discovery, and the profound impact biotech has on patients and society as a whole.
Kicking off the fall season, the podcast will feature David Fajgenbaum, MD, MBA, MSc, FCPP, a national bestselling author of “Chasing My Cure: A Doctor’s Race to Turn Hope into Action.” Dr. Fajgenbaum recounts his extraordinary journey from medical student to patient as he fought against a life-threatening disease. Through sheer determination and scientific acumen, Fajgenbaum uncovered an existing drug that could be repurposed to treat his disease—a discovery that saved his life and is now saving others.
This season’s “I am BIO” offers more insights into the world of biotechnology with upcoming episodes that will explore:
- The role of biotechnology in enhancing food security
- Inspiring patient stories and treatments in the pipeline that can help them
- The importance of biotechnology to national security
- GLP-1 drugs, benefits beyond weight loss
- Biotech solutions that support age-related health issues
Listen to past episodes on BIO’s website, Apple Podcasts, Google Podcasts, or Spotify.